Skip to content

Effectiveness of virtual reality training in amblyopia

Effectiveness of virtual reality training in amblyopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065464
Enrollment
Unknown
Registered
2022-11-04
Start date
2022-11-14
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amblyopia

Interventions

experimental group:Using visual function training treatment software (Model: SJ-JR2021)
control group:Cover therapy

Sponsors

The Second Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 7 Years

Inclusion criteria

Inclusion criteria: 1. Aged 4-7 years (including 4 and 7 years old), both sexes; 2. Monocular amblyopia was diagnosed; 3. The corrected visual acuity of amblyopia is between 0.2 (inclusive) and 0.6, and the binocular visual difference is more than 2 lines; 4. The guardian of the subject can understand the purpose of the trial and sign the informed consent. The subject can cooperate with the treatment and related ophthalmic examination.

Exclusion criteria

Exclusion criteria: 1. The subject has tumor, heart disease, hypertension and epilepsy; 2. The subject has an implanted electronic device, such as a pacemaker; 3. The subject has suffered from mental illness; 4. Subject suffers from vertigo, fear of heights or brain trauma; 5. The subject has photophobia and tears caused by keratitis, conjunctivitis, internal trichiasis and other diseases at any time; 6. The subject has strabismus or congenital cataract, congenital ptosis, trauma and other ocular organic lesions and related surgical history; 7. Subject has had any form of treatment for amblyopia other than refractive correction and covering treatment; 8. Other conditions, such as severe heart, liver and kidney disease, under which the investigator considers that the patient should not participate in the trial for safety reasons or in the interest of the patient.

Design outcomes

Primary

MeasureTime frame
Best corrected visual acuity;

Secondary

MeasureTime frame
Near stereopsis;contrast sensitivity;

Countries

China

Contacts

Public ContactTang Xiajing

The Second Affiliated Hospital of Zhejiang University School of Medicine

xiajingtang@zju.edu.cn+86 13732227517

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026